Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Scarab Genomics, Lonza sign Clean Genome E coli marketing agreement
As per the terms of the agreement, Lonza is expected to market Scarab Genomics’Clean Genome technology, giving Lonza customers full access to the platform for protein and plasmid
As per the terms of the agreement, Lonza is expected to market Scarab Genomics’Clean Genome technology, giving Lonza customers full access to the platform for protein and plasmid
The recall has been initiated by Abbott following an internal quality review, which detected the remote possibility of the presence of a small common beetle in the product
PNT2258 is an oligonucleotide therapeutic encapsulated within Marina Biotech’s proprietary Smarticles delivery technology. The Smarticles delivery technologywas developed by Novosom and acquired by Marina Biotech in July 2010.
RapID, developed in collaboration with ZyGem as a Lockheed Martin Technology innovation initiative, leverages the latest in microfluidic research and development to accelerate the DNA identification process essentially
As per the terms of the agreement, Rapid Micro Biosystems is expected to receive $2.2m in the first contract year and up to an additional $4.5m in two
Phase II clinical study was a double-blind, randomised, placebo-controlled, parallel-group trial designed to evaluate Sativex in patients with MS and overactive bladder (OAB) that was not responding adequately
Microbia claimed that it has developed a technology platform that enables it to produce high-quality, natural carotenoids (including ß-carotene and canthaxanthin), nutritional products and other specialty materials and
In addition,GATC Biotech said that the future application to enable direct sequencing of methylated bases will make the system attractive for regulatory studies for the pharmaceutical or diagnostics
The company claims that its Safety Syringe functions as a fully automatic, self-sheathing syringe, as specified by the OSHA mandate, that can be used in essentially all applications
The rFVIIIFc molecule, which is based on Biogen Idec’s new and proprietary monomeric Fc- fusion technology, is being investigated for the potential to prolong protection from bleeding and